抗凝药疗法针对败血症引起的散布性血管内凝血
Yutaka Umemura1,2, Takeshi Nishida1,2, Kazuma Yamakawa3
1Division of Trauma and Surgical Critical Care Osaka General Medical Center Osaka Japan.
Acute medicine & surgery
|September 6, 2023
概括
抗凝固药疗法可能无法改善败血症的整体生存率. 然而,有证据表明,它们可能会降低患有严重败血症诱导的传播性血管内凝血 (DIC) 患者的死亡率.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 传播性血管内凝血 (DIC) 是败血症的一种严重并发症.
- 针对败血症诱导的凝血病,已经研究了抗凝血疗法.
- 目前的证据并不总是显示这些疗法对败血症的生存益处.
研究的目的:
- 评估抗凝固药治疗在败血症中的疗效.
- 为了确定最佳的患者群体,用于抗凝血剂治疗败血症.
- 为指导未来关于抗凝剂在败血症中的使用的研究.
主要方法:
- 随机对照试验 (RCT) 对败血症抗凝药疗法的综述.
- 观察性研究和元分析的分析.
- 评估患者选择标准和疾病严重程度.
主要成果:
- 抗凝血剂在败血症中对整体生存的益处并未始终得到证实.
- 有证据表明,在败血症诱导的DIC中,抗凝剂可能会降低死亡率.
- 疾病的严重程度是影响治疗疗效的关键因素.
结论:
- 抗凝固疗法可能对特定的败血症亚群有益,特别是那些有明显DIC的亚群.
- 未来的RCT应专注于患有败血症引起的明显DIC和高疾病严重程度的患者.
- 开发基础设施,精确选择患者对于未来的研究至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
749
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
749
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
560
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
560
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14


